Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial
- PMID: 39458544
- PMCID: PMC11510205
- DOI: 10.3390/nu16203550
Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial
Abstract
Background/objectives: Collagen is a protein formed by very long amino acid chains. When conveniently treated, it can incorporate water into the net, thus increasing its volume and mass. The present work aimed to evaluate the potential anti-obesity effects of bovine collagen that has been technologically treated to increase its water retention capacity in an acid pH medium, with the objective of inducing satiation.
Methods: Collagen's digestibility was tested with a pepsin digestion test. Its swelling capacity was tested in an acid pH medium simulating gastric conditions. Postprandial levels of ghrelin in response to collagen supplementation were tested in rats. In a randomized control trial, 64 subjects with overweight/obesity were allocated in two groups: supplemented daily with two protein bars enriched with collagen (20 g per day) for 12 weeks, or control group. Anthropometric and biochemical measurements were assessed in all the participants.
Results: This collagen showed a low digestibility (<60%) and high swelling capacity (>1900%) in vitro. In humans with overweight and obesity, this collagen significantly reduced body weight, body mass index (BMI), systolic blood pressure (SBP), and fatty liver index (FLI) and increased fat-free mass when compared with the control group. A significant reduction in the sarcopenic index; total, troncular, and visceral fat (measured by DEXA); and serum leptin levels were observed in the collagen group at the end of the intervention, with no differences with respect to controls. Collagen reduced the sensation of hunger and increased fullness and satisfaction. In male Wistar rats, collagen decreased postprandial blood ghrelin levels.
Conclusions: Collagen supplementation (20 g per day for 12 weeks) reduced body weight, BMI, waist circumference, fat mass, FLI, and SBP in humans with overweight and obesity, which might be related to the increased sensation of fullness and satisfaction reported by the volunteers after the intake.
Keywords: blood pressure; fatty liver; ghrelin; obesity; sarcopenic index; satiation.
Conflict of interest statement
The Center for Nutrition Research receives funds for research from Viscofan. I.G.-S., J.M.I., and J.I.R. are employed by Viscofan S.A.
Figures





Similar articles
-
Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.Gastroenterology. 2015 Mar;148(3):537-546.e4. doi: 10.1053/j.gastro.2014.11.020. Epub 2014 Dec 6. Gastroenterology. 2015. PMID: 25486131 Free PMC article. Clinical Trial.
-
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.Gastroenterology. 2006 Dec;131(6):1717-24. doi: 10.1053/j.gastro.2006.10.025. Epub 2006 Oct 15. Gastroenterology. 2006. PMID: 17087952
-
Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants.Nutr J. 2015 Jan 3;14:2. doi: 10.1186/1475-2891-14-2. Nutr J. 2015. PMID: 25555562 Free PMC article. Clinical Trial.
-
Interventions for weight loss in people with chronic kidney disease who are overweight or obese.Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013119. doi: 10.1002/14651858.CD013119.pub2. Cochrane Database Syst Rev. 2021. PMID: 33782940 Free PMC article.
-
Does an increased intake of added sugar affect appetite in overweight or obese adults, when compared with lower intakes? A systematic review of the literature.Br J Nutr. 2019 Jan;121(2):232-240. doi: 10.1017/S0007114518003239. Epub 2018 Nov 29. Br J Nutr. 2019. PMID: 30489234
References
-
- Hansen T.T., Andersen S.V., Astrup A., Blundell J., Sjödin A. Is Reducing Appetite Beneficial for Body Weight Management in the Context of Overweight and Obesity? A Systematic Review and Meta-Analysis from Clinical Trials Assessing Body Weight Management after Exposure to Satiety Enhancing and/or Hunger Reducing Products. Obes. Rev. 2019;20:983–997. doi: 10.1111/OBR.12854. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical